quinapril and atenolol
quinapril has been researched along with atenolol in 17 studies
Research
Studies (17)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (41.18) | 18.2507 |
2000's | 5 (29.41) | 29.6817 |
2010's | 5 (29.41) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Goldstein, RJ | 1 |
Arvola, P; Koskenvuo, K; Laitinen, LA; Manninen, V; Metsä-Ketelä, T; Nurmi, AK; Pörsti, I; Säynävälammi, P; Vapaatalo, H | 1 |
Arvola, P; Kähönen, M; Mäkynen, H; Manninen, V; Pörsti, I; Vapaatalo, H; Wuorela, H | 1 |
Beaulieu, M; Cléroux, J; Kouamé, N; Lacourcière, Y | 1 |
Beaulieu, M; Cléroux, J; Lacourcière, Y; Lemieux, SC | 1 |
Lacourcière, Y; Lefebvre, J; Poirier, L; Provencher, P | 1 |
Barenbrock, M; Hausberg, M; Heidenreich, S; Hohage, H; Müller, S; Rahn, KH | 1 |
Gerhardt, U; Hausberg, M; Hohage, H; Rahn, KH; Suwelack, B | 1 |
Roberge, RJ; Rosetti, JM; Rossetti, ML | 1 |
Erfmann, M; Gerhardt, U; Hausberg, M; Hohage, H; Kobelt, V; Rahn, KH; Suwelack, B | 1 |
Reviews
2 review(s) available for quinapril and atenolol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The treatment of moderate to severe hypertension with ACE inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Atenolol; Captopril; Double-Blind Method; Drug Therapy, Combination; Enalapril; Humans; Hydrochlorothiazide; Hypertension; Isoquinolines; Multicenter Studies as Topic; Quinapril; Tetrahydroisoquinolines | 1990 |
Trials
8 trial(s) available for quinapril and atenolol
Article | Year |
---|---|
The treatment of moderate to severe hypertension with ACE inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Atenolol; Captopril; Double-Blind Method; Drug Therapy, Combination; Enalapril; Humans; Hydrochlorothiazide; Hypertension; Isoquinolines; Multicenter Studies as Topic; Quinapril; Tetrahydroisoquinolines | 1990 |
Effects of single doses of quinapril and atenolol on autonomic nervous function and exercise capacity in healthy volunteers.
Topics: Adult; Atenolol; Autonomic Nervous System; Blood Pressure; Cold Temperature; Double-Blind Method; Epinephrine; Exercise; Heart; Heart Rate; Humans; Isoquinolines; Male; Norepinephrine; Posture; Quinapril; Renin; Tetrahydroisoquinolines; Valsalva Maneuver | 1990 |
Comparative effects of quinapril, atenolol, and verapamil on blood pressure and forearm hemodynamics during handgrip exercise.
Topics: Angiotensin-Converting Enzyme Inhibitors; Atenolol; Blood Pressure; Cross-Over Studies; Double-Blind Method; Exercise; Forearm; Heart Rate; Humans; Hypertension; Isoquinolines; Middle Aged; Quinapril; Tetrahydroisoquinolines; Vascular Resistance; Verapamil | 1994 |
Effects of quinapril and verapamil versus atenolol on blood pressure during dynamic leg exercise.
Topics: Angiotensin-Converting Enzyme Inhibitors; Atenolol; Blood Pressure; Double-Blind Method; Exercise; Humans; Hypertension; Isoquinolines; Leg; Middle Aged; Quinapril; Tetrahydroisoquinolines; Verapamil | 1993 |
Comparison of quinapril and atenolol as single drugs or in combination with hydrochlorothiazide in moderate to severe hypertensives, using automated ambulatory monitoring.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Isoquinolines; Male; Middle Aged; Monitoring, Physiologic; Quinapril; Tetrahydroisoquinolines; Triglycerides | 1993 |
ACE inhibitor versus beta-blocker for the treatment of hypertension in renal allograft recipients.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Blood Pressure; Creatinine; Cyclosporine; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Immunosuppressive Agents; Isoquinolines; Kidney Transplantation; Male; Middle Aged; Proteinuria; Quinapril; Tetrahydroisoquinolines | 1999 |
Comparison of quinapril versus atenolol: effects on blood pressure and cardiac mass after renal transplantation.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Diastole; Double-Blind Method; Heart Ventricles; Humans; Hypertension; Hypertrophy, Left Ventricular; Isoquinolines; Kidney Transplantation; Middle Aged; Quinapril; Tetrahydroisoquinolines; Ventricular Function | 2000 |
Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients.
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Blood Pressure; Female; Follow-Up Studies; Hemoglobins; Humans; Hypertension, Renal; Immunosuppression Therapy; Kidney; Kidney Transplantation; Male; Prospective Studies; Quinapril; Tetrahydroisoquinolines; Transplantation, Homologous | 2003 |
Other Studies
8 other study(ies) available for quinapril and atenolol
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
High calcium diet, different antihypertensive agents, and cytosolic free Ca2+ in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Atenolol; Blood Pressure; Calcium; Calcium, Dietary; Cytosol; Drug Interactions; Isoquinolines; Male; Quinapril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrahydroisoquinolines; Trichlormethiazide | 1993 |
Aminophylline reversal of antihypertensive agent toxicity.
Topics: Adrenergic beta-Antagonists; Aminophylline; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Cardiotonic Agents; Drug Overdose; Female; Fluvoxamine; Humans; Hypotension; Isoquinolines; Middle Aged; Quinapril; Selective Serotonin Reuptake Inhibitors; Tetrahydroisoquinolines; Treatment Outcome | 2001 |